GRNA — Greenlight Biosciences Holdings PBC Cashflow Statement
0.000.00%
Last trade - 00:00HealthcareSpeculativeMicro Cap
- $45.43m
- $37.72m
- $6.78m
Annual cashflow statement for Greenlight Biosciences Holdings PBC, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | |
|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M |
| Source: | PROSPECTUS | PROSPECTUS | 10-K |
| Standards: | USG | USG | USG |
| Status: | Final | Final | Final |
| Net Income/Starting Line | — | -112 | -167 |
| Depreciation | |||
| Non-Cash Items | — | 4.18 | 13.8 |
| Unusual Items | |||
| Other Non-Cash Items | |||
| Changes in Working Capital | — | 10.5 | 8.41 |
| Change in Prepaid Expenses | |||
| Change in Accounts Payable | |||
| Change in Accrued Expenses | |||
| Change in Other Liabilities | |||
| Cash from Operating Activities | — | -91.8 | -137 |
| Capital Expenditures | — | -15.1 | -26.5 |
| Purchase of Fixed Assets | |||
| Other Investing Cash Flow Items | — | 0.109 | 0.037 |
| Sale of Fixed Assets | |||
| Cash from Investing Activities | — | -15 | -26.5 |
| Financing Cash Flow Items | — | -3.02 | 78.5 |
| Other Financing Cash Flow | |||
| Net Issuance / Retirement of Stock | |||
| Net Issuance / Retirement of Debt | |||
| Cash from Financing Activities | — | 45.3 | 201 |
| Beginning Cash Balance | |||
| Ending Cash Balance | |||
| Net Change in Cash | 0 | -63.3 | 37.6 |